KMPlotter analysis of NEK6 expression reveals positive patient survival correlations with esophageal adenocarcinoma, kidney renal cell carcinoma, rectum adenocarcinoma, and uterine corpus endometrial carcinoma (HR < 1, p-value < 0.05) and negative correlations with survival in bladder carcinoma, cervical squamous cell carcinoma, head and neck squamous cell carcinoma, liver hepatocellular carcinoma, lung squamous cell carcinoma, ovarian cancer, pancreatic ductal carcinoma, and sarcoma (HR > 1, p-value < 0.05) (Table 1). Here, NEK6 is linked to uterine corpus endometrial carcinoma.